BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 26558036)

  • 21. Evaluation and medical management of kidney stones in children.
    Tasian GE; Copelovitch L
    J Urol; 2014 Nov; 192(5):1329-36. PubMed ID: 24960469
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
    Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
    J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Adjustment of urine PH as effective tool for successful metaphylaxis of urinary stone disease. phytotherapy].
    Saenko VS; Lachinov EL; Zhantlisov DA; Gorbachev MI; Soltanov AA
    Urologiia; 2020 Jun; (3):104-110. PubMed ID: 32597596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased water intake as a prevention strategy for recurrent urolithiasis: major impact of compliance on cost-effectiveness.
    Lotan Y; Buendia Jiménez I; Lenoir-Wijnkoop I; Daudon M; Molinier L; Tack I; Nuijten MJ
    J Urol; 2013 Mar; 189(3):935-9. PubMed ID: 23017509
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic Work-up of Patients with Urolithiasis: Indications and Diagnostic Algorithm.
    Tiselius HG; Daudon M; Thomas K; Seitz C
    Eur Urol Focus; 2017 Feb; 3(1):62-71. PubMed ID: 28720369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosis and metaphylaxis of stone disease. Consensus concept of the National Working Committee on Stone Disease for the upcoming German Urolithiasis Guideline.
    Straub M; Strohmaier WL; Berg W; Beck B; Hoppe B; Laube N; Lahme S; Schmidt M; Hesse A; Koehrmann KU
    World J Urol; 2005 Nov; 23(5):309-23. PubMed ID: 16315051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Flexible ureterorenoscopy vs percutaneous nephrolithotomy for renal stone management: Retrospective study].
    Palmero X; Balssa L; Bernardini S; Chabannes E; Guichard G; Bittard H; Kleinclauss F
    Prog Urol; 2016 Sep; 26(9):500-6. PubMed ID: 27592745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic assessment of recurrent and first renal calcium oxalate stone formers.
    Çakıroğlu B; Eyyupoğlu E; Hazar AI; Uyanik BS; Nuhoğlu B
    Arch Ital Urol Androl; 2016 Jul; 88(2):101-5. PubMed ID: 27377084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of socioeconomic status in etiology and management of urinary stone disease.
    Ansari MS; Gupta NP
    Urol Int; 2003; 70(4):255-61. PubMed ID: 12776701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Burden of Urolithiasis: Trends in Prevalence, Treatments, and Costs.
    Raheem OA; Khandwala YS; Sur RL; Ghani KR; Denstedt JD
    Eur Urol Focus; 2017 Feb; 3(1):18-26. PubMed ID: 28720363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paediatric urolithiasis in emerging economies.
    Rizvi SA; Sultan S; Zafar MN; Ahmed B; Aba Umer S; Naqvi SA
    Int J Surg; 2016 Dec; 36(Pt D):705-712. PubMed ID: 27865972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stress-stones-stress-recurrent stones: a self-propagating cycle? Difficulties in solving this dichotomy.
    Arzoz-Fabregas M; Roca-Antonio J; Ibarz-Servio L; Jappie-Mahomed D; Rodgers A
    Urolithiasis; 2017 Dec; 45(6):515-524. PubMed ID: 28324150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antioxidative activity and clinical efficiency of dietary supplements Nefradoz for treatment of recurrent calcium oxalate urolithiasis].
    Kamalov AA; Okhobotov DA; Proskurnina EV; Sozarukova MM; Nizov AN
    Urologiia; 2018 Dec; (6):52-59. PubMed ID: 30742378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 24 Hour urine metabolic differences between solitary and multiple stone formers: Results of the Collaboration on Urolithiasis in Pediatrics (CUP) working group.
    Saitz TR; Mongoue-Tchokote S; Sharadin C; Giel DW; Corbett S; Kovacevic L; Bayne AP;
    J Pediatr Urol; 2017 Oct; 13(5):506.e1-506.e5. PubMed ID: 28526618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Metaphylaxis of urolithiasis - a neglected field in medicine?].
    Kościelska M; Mieczkowski M
    Wiad Lek; 2016; 69(5):736-741. PubMed ID: 28033598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Economics and cost of care of stone disease.
    Lotan Y
    Adv Chronic Kidney Dis; 2009 Jan; 16(1):5-10. PubMed ID: 19095200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi].
    Hess B
    Ther Umsch; 2003 Feb; 60(2):79-87. PubMed ID: 12649986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does open stone surgery still play a role in the treatment of urolithiasis? Data of a primary urolithiasis center.
    Honeck P; Wendt-Nordahl G; Krombach P; Bach T; Häcker A; Alken P; Michel MS
    J Endourol; 2009 Jul; 23(7):1209-12. PubMed ID: 19538063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Functional evaluation in patients with kidney calculi].
    Stojimirović B
    Srp Arh Celok Lek; 1998; 126(9-10):394-8. PubMed ID: 9863414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [DIAGNOSIS OF METABOLIC DISORDERS AND METAPHYLAXIS OF RECURRENT CALCIUM OXALATE UROLITHIASIS].
    Kustov AV; Strelnikov AL; Airapetyan AO; Moryganov MA; Zhuravleva NI
    Urologiia; 2015; (5):86-8. PubMed ID: 26859947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.